Загрузка...
Ocrelizumab-Induced Severe Colitis
We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.
Сохранить в:
| Опубликовано в: : | Case Rep Gastrointest Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737437/ https://ncbi.nlm.nih.gov/pubmed/33354373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8858378 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|